Medicare Advantage Accelerates Claims Approval for Exoskeleton Devices
Lifeward reports accelerated Medicare Advantage claims approvals for ReWalk 7 Exoskeleton, improving access and payment timelines in 2025.
Innovative Insurers Adopting AUVI-Q to Cut Healthcare Costs
Discover how insurers like Aetna are covering AUVI-Q to reduce healthcare costs and enhance patient safety. Explore the industry's strategic decisions.
Medicare Coverage for Portable Oxygen Concentrators
Explore Medicare coverage options for portable oxygen concentrators like Inogen One, promoting user independence and mobility with compact design and reliable battery life.
FDA Reassigns Director of Office of Nonprescription Drugs Amid Strategic Shift
The FDA has reassigned the director of its Office of Nonprescription Drugs to a medical devices leadership role, highlighting a strategic shift toward affordability and regulatory realignment. This change may impact drug approval policies and insurance regulatory compliance.
CMS Grants NTAP for Renata Medical's Pediatric Minima Stent System
CMS approves New Technology Add-on Payment for Renata Medical's Minima stent, enabling enhanced reimbursement for innovative pediatric congenital heart disease treatment.
Nexalin Backing Senate Bill to Expand Medicare AI Device Reimbursement
Nexalin supports bipartisan Health Tech Investment Act to expand Medicare reimbursement for FDA-approved AI medical devices, aiding innovation in mental health treatment.
Senate Bill Proposes Clear Medicare Payment Pathway for AI Medical Devices
The Health Tech Investment Act aims to create a consistent Medicare payment system for FDA-approved AI medical devices, enhancing patient access and improving healthcare outcomes.